Hypothermia for newborns with hypoxic ischemic encephalopathy

Area of Science:

• Neonatal neurology
• Pediatric critical care
• Perinatal medicine

Background:

• Hypoxic ischemic encephalopathy (HIE) is a major cause of infant mortality and long-term disability.
• HIE affects late preterm and term infants, often resulting from birth complications.

Purpose of the Study:

• To evaluate the efficacy and safety of mild therapeutic hypothermia in term and late preterm infants with HIE.
• To determine the optimal timing and criteria for initiating therapeutic hypothermia.

Main Methods:

• Mild therapeutic hypothermia initiated within 6 hours of birth.
• Target rectal temperature of 34±0.5°C.
• Assessment of infants ≥36 weeks' gestational age who are depressed at birth.

Main Results:

• Therapeutic hypothermia decreases mortality and severe neurodevelopmental disabilities in infants with moderate HIE (≥36 weeks' gestational age).
• Minimal side effects observed; no increased incidence of disability in survivors.
• Infants with severe encephalopathy showed less benefit from cooling.

Conclusions:

• Therapeutic hypothermia is a standard of care for moderate HIE in term and late preterm infants (≥36 weeks' gestational age).
• Early initiation (within 6 hours) is crucial for optimal outcomes.
• No demonstrated benefit for infants <36 weeks' gestational age or those with severe HIE.